Figure 8.
Figure 8. Constitutive PMN apoptosis in the presence of NBD or control peptide. Cells were incubated with buffer control (cells), TAT-NBD (N), or mutant control peptide (c). After 20 hours, cells were harvested and the percentage of apoptotic PMNs was assayed by flow cytometry using (A) propidium iodide (PI; n = 4) or (B) annexin V staining (n = 4). **P < .01 when compared with untreated cells. The values represent mean ± SEM. (C) A typical experiment with both assays performed in parallel is depicted using a peptide concentration at 100 μM. The data indicate that TAT-NBD (NBD) accelerated apoptosis in a dose-dependent fashion over a range of 1 to 200 μM. In contrast, no effect was seen in the presence of a mutant control peptide (MUT). The percentage of apoptotic cells is indicated by the marker.

Constitutive PMN apoptosis in the presence of NBD or control peptide. Cells were incubated with buffer control (cells), TAT-NBD (N), or mutant control peptide (c). After 20 hours, cells were harvested and the percentage of apoptotic PMNs was assayed by flow cytometry using (A) propidium iodide (PI; n = 4) or (B) annexin V staining (n = 4). **P < .01 when compared with untreated cells. The values represent mean ± SEM. (C) A typical experiment with both assays performed in parallel is depicted using a peptide concentration at 100 μM. The data indicate that TAT-NBD (NBD) accelerated apoptosis in a dose-dependent fashion over a range of 1 to 200 μM. In contrast, no effect was seen in the presence of a mutant control peptide (MUT). The percentage of apoptotic cells is indicated by the marker.

Close Modal

or Create an Account

Close Modal
Close Modal